Search Count: 13
 |
Biological And Structural Analysis Of New Potent Integrase-Ledgf Allosteric Hiv-1 Inhibitors
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: RWR, MG, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: RWR, MG, SO4
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Bdm-2
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: RWR, EDO, CL, MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: RWR, EDO, CL, MG
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Mut871
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: EDO, CL, U5L, MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: EDO, CL, U5L, MG
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Mut872
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: W2Q, EDO, MG, PEG, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: W2Q, EDO, MG, PEG, CL
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Mut884
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.44 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: CL, EDO, U60, MG, PGE |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: CL, EDO, U60, MG, PGE
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Mut916
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2023-06-07 Classification: VIRAL PROTEIN Ligands: EDO, PEG, U5S, MG, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-06-07
Ligands: EDO, PEG, U5S, MG, CL
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VN, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VN, SO4
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: 9VK, MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: 9VK, MG
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VN, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VN, SO4
 |
Dissociation Of Biochemical And Antiretroviral Activities Of Integrase-Ledgf Allosteric Inhibitors Revealed By Resistance Of A125 Polymorphic Hiv-1
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-03-07 Classification: VIRAL PROTEIN Ligands: MG, 9VK, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MG, 9VK, SO4
 |
Dual Inhibition Of Hiv-1 Replication By Integrase-Ledgf Allosteric Inhibitors Is Predominant At Post-Integration Stage During Virus Production Rather Than At Integration
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-12-25 Classification: TRANSFERASE Ligands: MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-12-25
Ligands: MG
 |
Dual Inhibition Of Hiv-1 Replication By Integrase-Ledgf Allosteric Inhibitors Is Predominant At Post-Integration Stage During Virus Production Rather Than At Integration
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2013-12-25 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: LF0, MG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-12-25
Ligands: LF0, MG